Latelines for March 17, 2003
Icotrokinra Shows High Rates of Skin Clearance in Scalp, Genital Psoriasis
In a phase 3 study, 57% of patients treated with icotrokinra achieved an Investigator's Global Assessment score of 1 or 0 and a grade 2 or more improvement at week 16.
Demystifying PBMs, Their Role in the Drug Supply Chain
President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.
President Trump Signs Executive Order Significantly Decreasing US Drug Prices
The order is set to make patients’ prescription costs similar to other nations with the lowest-priced drugs in the world.
Scripted for Her: Helping Patients Choose Contraceptive Methods
In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.
Q&A: Douglas Hoey on How Rite Aid’s Closure Will Impact Independent Pharmacies
Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chain’s situation means for the pharmacy landscape.
Q&A: What AI Is, How It’s Helping Pharmacies with Compliance | NCPDP 2025
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.
